PunjiPUNJI
Live AI ↗
Pharmaceuticals & BiotechnologyLarge Cap

Divi's Laboratories Ltd.

DIVISLAB · ISIN: INE361B01024

Constituent of NIFTY 100 TRI (0.74%), NIFTY 50 (0.58%), NIFTY 500 TRI (0.51%), NIFTY LMC 250 TRI (0.37%), NIFTY MC 150 TRI (2.47%)

Close (as of 2026-09-08)
₹9575
+2.79% today
Day Range
₹9253 - ₹9588
Quality Score (as of 2026-06-30)
60/100

Earnings (TTM)

CHART

Divi's Laboratories Ltd. - revenue & profit (TTM)

Trailing-twelve-month figures by reported quarter, in ₹ Cr. Latest quarter: 2026-06-30.

0 Cr314440 Cr628880 Cr943320 Cr1257760 CrQ2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Revenue (TTM)PAT (TTM)

34.38%

EBITDA Margin (TTM)

110.21

EPS (TTM)

7.6%

EPS Growth (5Y)

9.63%

EPS Growth (10Y)

Technicals

73.44

RSI (14)

8039.35

SMA (50)

6798.95

SMA (200)

66.45

ADX (14)

9588

52-Week High

5636.5

52-Week Low

56.44%

1Y Return

400.7787

Avg Traded Value (20D, ₹Cr)

As of 2026-09-08.

Shareholding Pattern

CHART

Shareholding by category

As of 2026-06-30.

51.88%48.12%TOP 2100%
Promoter 51.88%Public 48.12%

F&O Sentiment

Nearest expiry: 2026-09-29 · As of 2026-09-07.

0.9243

PCR (OI)

0.4217

PCR (Volume)

9000

Max Pain Strike

Corporate Actions

Ex-DateTypeRatioDetails
2015-09-23BONUS0.500000 BONUS 1:1
2009-07-30BONUS0.500000BONUS-1:1

Recent Deals

No recent block/bulk/short-sell deals on record for this stock.

Stock data · Not financial advice · Past performance does not indicate future returns